The timing and planning of the submission of applications and the timetable for assessment of applications is important for applicants, marketing-authorisation holders (MAHs), the European Medicines Agency, and members and experts of the Committee for Medicinal Products for Human Use (CHMP), the Pharmacovigilance Risk Assessment Committee (PRAC) and the Committee for Advanced Therapies (CAT).Timing applications appropriately enables the working plan to be as efficient as possible.
The Agency advises applicants to consider the date of submission very carefully, particularly for full applications.
Applicants should notify the Agency, and the CHMP, PRAC or CAT Rapporteurs and the Co-Rapporteurs of their actual submission date (for full applications, see also question 8 of the pre-submission questions and answers).
Deadlines and timetables
Timetables are published as a generic calendar and are for the information and use of applicants, MAHs, the European Medicines Agency, CHMP, PRAC or CAT members and assessment teams.
- See the full list of procedural timetables.
How useful is this page?
Average rating:Based on 41 ratings
Add your rating:
- See all ratings
16 ratings3 ratings5 ratings4 ratings13 ratings